Daiwa Securities Group
RVMD icon

Daiwa Securities Group’s Revolution Medicines RVMD Stock Holding History

Daiwa Securities Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15M Buy
22,169
+2,565
+13% +$375K 0.01% 553
2026
Q1 		$1.91M Buy
19,604
+12,769
+187% +$1.29M 0.01% 658
2025
Q4 		$545K Sell
6,835
-2
-0% -$131 ﹤0.01% 872
2025
Q3 		$319K Sell
6,837
-998
-13% -$39.1K ﹤0.01% 943
2025
Q2 		$288K Buy
7,835
+3,689
+89% +$142K ﹤0.01% 920
2025
Q1 		$147K Buy
4,146
+359
+9% +$14.6K ﹤0.01% 953
2024
Q4 		$165K Buy
3,787
+3,178
+522% +$160K ﹤0.01% 954
2024
Q3 		$28K Hold
609
– – ﹤0.01% 1090
2024
Q2 		$24K Hold
609
– – ﹤0.01% 1130
2024
Q1 		$20K Sell
609
-61
-9% -$1.81K ﹤0.01% 1138
2023
Q4 		$19K Buy
670
+313
+88% +$7.52K ﹤0.01% 1131
2023
Q3 		$10K Hold
357
– – ﹤0.01% 1128
2023
Q2 		$10K Hold
357
– – ﹤0.01% 1139
2023
Q1 		$8K Hold
357
– – ﹤0.01% 1126
2022
Q4 		$9K Buy
357
+80
+29% +$1.7K ﹤0.01% 1119
2022
Q3 		$5K Hold
277
– – ﹤0.01% 1163
2022
Q2 		$5K Buy
277
+62
+29% +$1.21K ﹤0.01% 1172
2022
Q1 		$5K Hold
215
– – ﹤0.01% 1177
2021
Q4 		$5K Sell
215
-37
-15% -$1.04K ﹤0.01% 1203
2021
Q3 		$7K Buy
252
+109
+76% +$3.17K ﹤0.01% 1160
2021
Q2 		$5K Hold
143
– – ﹤0.01% 1078
2021
Q1 		$7K Buy
143
+18
+14% +$807 ﹤0.01% 1061
2020
Q4 		$5K Buy
+125
New +$4.94K ﹤0.01% 1057

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Daiwa Securities Group's RVMD Position: Q2 2026 in Review

Daiwa Securities Group increased its Revolution Medicines (RVMD) stake by 13% in Q2 2026, buying an estimated $375K and bringing the position to 22,169 shares worth $4.15M. The position accounts for 0.01% of the portfolio, ranked #553.

Daiwa Securities Group first reported a position in RVMD in Q4 2020 and has held it in 23 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Daiwa Securities Group held 22,169 shares of Revolution Medicines worth $4.15M as of Q2 2026.
  • Daiwa Securities Group bought 2,565 Revolution Medicines shares in Q2 2026, an estimated $375K.
  • Revolution Medicines made up 0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #553 holding.
  • Daiwa Securities Group first reported a position in Revolution Medicines in Q4 2020 and has held it in 23 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.